Share Twitter LinkedIn Facebook Email Ruben Mesa, MD from UT Health San Antonio Cancer Center discusses individualized medicine in 2018 and therapies based on tumor specimens, incorporation of patient input at the 2017 American Society of Hematology.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read